eudragit-e has been researched along with oxazoles in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoon Jeong, S; Park, ES; Park, SJ; Seo, HJ; Thapa, P | 1 |
1 trial(s) available for eudragit-e and oxazoles
Article | Year |
---|---|
Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation.
Topics: Administration, Oral; Adult; Animals; Anticholesteremic Agents; Biological Availability; Cellulose; Cholesterol Ester Transfer Proteins; Double-Blind Method; Drug Carriers; Drug Compounding; Drug Development; Excipients; Female; Humans; Hydrocarbons, Fluorinated; Macaca mulatta; Male; Mannitol; Middle Aged; Models, Biological; Oxazoles; Permeability; Poloxamer; Polymethacrylic Acids; Proof of Concept Study; Solubility; Tablets; Young Adult | 2018 |